Standard Chem & Pharm (1720.TW) Earnings Analysis

Standard Chem & Pharm (1720.TW) next reports earnings on 2026-08-12. Last quarter (2025-11-07) it beat with EPS 1.72 TWD vs 1.36 TWD est (+26.5%). It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E 10.39.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 1720.TW next report earnings?

Next earnings date2026-08-12
Consensus EPS estimaten/a
Revenue estimaten/a

1720.TW earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2025-11-071.72 TWD1.36 TWD+26.5%Beat
2025-05-091.09 TWD1.12 TWD-2.7%Miss
2024-11-081.22 TWD1.31 TWD-6.9%Miss

Beat rate: 1/3 (33%) over reported quarters with consensus data.

1720.TW valuation and analyst view

Trailing P/E10.39
Trailing EPS4.199 TWD
Price / book2.13
Dividend yield3.57%
Market cap11.35B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Standard Chem & Pharm (1720.TW)'s next earnings date?

Standard Chem & Pharm is next scheduled to report on 2026-08-12.

Did 1720.TW beat earnings last quarter?

In its 2025-11-07 report, 1720.TW posted EPS of 1.72 TWD versus a 1.36 TWD estimate — a beat of 26.5%.

What is 1720.TW's earnings track record?

Over the last 3 reported quarters with consensus data, 1720.TW beat estimates 1 times (33%).

What is 1720.TW's current P/E ratio and EPS?

1720.TW trades at a trailing P/E of 10.39 on trailing EPS of 4.199227644577186 TWD.

What do analysts rate 1720.TW?

1720.TW has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.